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Abstract
BACKGROUND: Localization and histopathological examination of sentinel lymph node is a standard of melanoma treatment. 
The first stage of identification of the SLN is the preoperative lymphoscintigraphy. The aim of this study was to assess and 
compare diagnostic value of planar lymphoscintigraphy and SPECT/CT in sentinel lymph node biopsy procedure performed 
in patients with cutaneous trunk melanoma.
MATERIAL AND METHODS: Between 2015 and 2016, patients with trunk melanoma (N = 255, F/M 95/160), aged from 17 to 
88 after an excisional biopsy, with primary tumor ≥ pT1b (AJCC 2009, median Breslow thickness 2.0 ± 3.13) were included in 
the study. In all the patients PL was followed by SPECT/CT 1–3 hours after injection of 
99m
Tc- colloid particles, and SLNB was 
performed the next day. 
RESULTS: SPECT-CT revealed 78 (18.6%) SLN more than PL, and in 40 patients showed additional lymph drainage regions 
leading to surgical adjustments. In 18 patients (7.1%) SPECT-CT revealed SLN not visible in the PL (false-negative PL) and in 
22 patients (8.6%), foci of uptake interpreted in PL as hot SLNs were found to be non-nodal sites of uptake when assessed on 
SPECT/CT (false positive PL). SPECT-CT vs. PL mismatch was observed in 31 patients (12.2%) and was the most common in 
patients with primary lesions located in the anterior inferior medial region (75%).
CONCLUSIONS: Results of the presented study indicates the high diagnostic value of SPECT-CT in assessment of SLNs and proved 
that SPECT-CT increases the sensitivity and accuracy of SLN identification as compared to PL even in very experienced hands. 
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Introduction
Skin melanoma is the leading cause of death from cuta-
neous malignancies, and the incidence rate in the last three 
decades has almost triplicated [1]. Radioisotopic evaluation of 
lymphatic drainage as a potential pathway for tumor spreading and 
a sentinel lymph node (SLN) search is a contemporary oncological 
standard in management of skin melanoma patients without clini-
cal features of lymph node involvement and distal metastases [2].
The sentinel lymph node (SLN) is defined as the first lymph 
node(s) receiving direct lymphatic drainage from the primary 
tumour. The concept and definition of SLN is derived from 
Gould’s works and its wider clinical application was published 
in the 1970s by Cabanas. [3, 4] However, only in the nineties of 
the last century has this procedure been introduced into clinical 
practice. Krag’s and Alex’s studies published at that time present 
an extensive use of planar lymphoscintigraphy (PL) in search of 
SLN in skin melanoma and breast cancer [5]. 
In skin melanoma patients, lymphatic drainage from primary 
lesions located in the trunk can be multidirectional and may include 
different basins [6].
Nuclear Medicine Review 2018, Vol. 21, No. 2
www.journals.viamedica.pl/nuclear_medicine_review80
Original
Sentinel lymph node biopsy (SLNB) procedure, so called triple 
technique, consists of preoperative lymphoscintigraphy, intraopera-
tive administration of dye (patent blue, isosulfan blue, methylene 
blue, indocyanine green) and finding the sentinel node in the opera-
tion area using handheld scintillation probe and visualization (“hot 
and blue”) then histopathological examination (serial examination 
with immunohistochemical staining).
Finding metastatic cells in a SLN in histopathological ex-
amination is, according to the current oncological standards, 
an indication for the radical lymph node dissection. In order to 
determine extent of surgical procedure and to minimize the risk of 
complications in therapeutic management in skin melanoma pa-
tients, it is necessary to locate and examine SLNs. Triple technique 
is a routine oncological practice at the Maria Sklodowska-Curie 
Institute — Oncology Center in Warsaw. The first stage of identi-
fication of the SLN is the preoperative lymphoscintigraphy, then 
intraoperative handheld probe verification and dye administration 
just before the operation (usually Patent Blau®). This technique 
allows to visualize the direction of the lymphatic drainage, deter-
mine the location and estimate the number of SLN, and visualize 
the SLN located outside of the anatomically defined regional 
lymphatic basin [7, 8].
Application of combined SLN identification techniques in-
creases the sensitivity and efficiency of the procedure. According 
to different authors, using only the dye in the search of the SLN 
has a sensitivity of 80 to 83%. The use of radiopharmaceutical 
only has sensitivity 90–94%, whereas, the combination of both 
methods increases the sensitivity to 97–99% [9, 10]. The optimal 
accomplishment of the procedure requires close cooperation 
between the nuclear medicine specialist, the operating surgeon 
and the pathologist [11].
Until recently, in the skin melanoma patients with primary lesion 
located on the trunk, radioisotope search for a SLN performed only 
by PL technique (anterior and posterior acquisition) was believed 
sufficient. Additional oblique projections were also considered, 
as allowing better anatomical localization of visualized lymph 
nodes [12].
Currently, according to the latest recommendations of the lead-
ing scientific societies in the field (European Association of Nuclear 
Medicine (EANM), the European Society of Surgical Oncology 
(ESMO), the American Society of Clinical Oncology (ASCO) and the 
Society of Surgical Oncology (SSO)) in patients with skin melanoma 
located on the trunk, as well as on the head and neck, it is neces-
sary to supplement the planar imaging with single-photon emis-
sion computed tomography (SPECT-CT) and three-dimensional 
reconstruction [13, 14]. This allows for much greater accuracy of 
anatomical localization and provides more information relevant for 
SLNB, making it the “gold standard” in skin melanoma and breast 
cancer diagnostic process [11, 15, 16]. Nevertheless the number 
of publications comparing both techniques (PLvs SPECT-CT lym-
phoscintigraphy) on large groups of patients is limited, especially 
single-centered.
Objective
The aim of this study was to assess and compare diagnostic 
value of PL and SPECT/CT in SLNB procedure performed in pa-
tients with cutaneous melanoma located on the trunk.
Material and methods
The study includes patients with skin melanoma located on the 
trunk, hospitalized in Maria Sklodowska-Curie Institute — Oncology 
Center (MSCI) in Warsaw — operated in the Department of Soft 
Tissue/Bone Sarcoma and Melanoma and diagnosed in the Depart-
ment of Endocrinological Oncology and Nuclear Medicine. During 
two years (2015–2016), 255 patients (95 women, 160 men), aged 
from 17 to 88 (median age 61) after an excisional biopsy, in stage 
of primary tumor ≥ pT1b (median Breslow thickness 2.0 ± 3.13 
[Me ± SD]) according to AJCC 2009 classification, were included 
in the study. The localization of the primary tumor at the trunk 
was categorized according to 12 anatomical regions, as presented 
and explained in Figure 1.
All patients included in the study underwent sentinel lymph node 
biopsy (SLNB). In the studied group radioisotope examinations were car-
ried out routinely using both imaging PL and SPECT-CT (single-photon 
emission computed tomography with multidetector 16 row CT fusion) 
with a three-dimensional reconstruction of the image. Radiopharma-
ceutical used in the preoperative lymphoscintigraphy was nanoalbumin 
(Nanocoll, GE Healthcare, Little Chalfont, GB) labeled with a techne-
tium isotope (99mTc). The data was obtained using SPECT-CT (Discovery 
NM/CT 670 GE Healthcare), as well as dynamic and static phase of 
PL, immediately following intradermal administration of radiocolloid 
with 5–20 MBq activity in 2–6 injections around the scar after the ex-
cisional biopsy. PL data acquisition was performed using a two-head 
gamma camera with low-energy high-resolution collimator on a 128 
x 128 or 256 ¥ 256 matrix. The energy window was adjusted to 99mTc 
(140 keV) with a tolerance of 15 ± 5%. The data was compiled using 
dedicated computer applications on workstations (Xeleris 3.1, GE 
Healthcare). The SLNB procedure was performed in accordance with 
the two-day protocol used in MSCI. The radioisotope was administered 
16–20 hours prior to surgery.
In the statistical analysis of the results obtained, data com-
patibility with the normal distribution was checked using the 
Shapiro-Wilk test. Parametric variables fulfilling normal distribution 
assumptions were analyzed by the t-test for dependent variables. In 
case of data inconsistency with normal distribution, the Mann-Whit-
ney-Wilcoxon test was used after ranking. To assess the impact of 
one grading factor (divided into multiple levels) on values of a tested 
measurable characteristic ANOVA variance analysis was used, or 
when breaking the assumptions, the Kruskal-Wallis test was applied. 
The threshold of statistical significance assumed was p ≤ 0.05. Per-
centages were rounded to the nearest integers. Calculations were 
performed using Statistica 12.5 (Tibco, Palo Alto, CA, USA), PQstat 
(PQStat Software, Poznan, Poland), and Microsoft Excel 2007 
(Microsoft Inc, Redmond, WA, USA) software.
Results
In the study group, melanoma was more common in men 
(p = 0.0464). In 59.6% (152 patients) skin melanoma was found 
on the posterior surface of the trunk. As shown in Figure 1, 190 
primary lesions were located on the upper part of the trunk and 65 
in the lower part. On the right side of the trunk, the lesions were 
found in 96 subjects, in the medial part of the body there were 46 
lesions, and in the left side of the body 113 lesions. There were no 
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differences in primary lesion localization neither between sexes, 
nor among the age groups.
Preoperative PL and SPECT-CT was conducted in all 255 
patients included in the study. It allowed to assess the localization 
and number of SLN, directions of lymphatic flow and also the ana-
tomical regions of lymphatic basin. In PL, there were 419 sentinel 
nodes revealed in 236 patients. The number of lymph nodes de-
tected in one patient ranged from 1 to 7, with an average of 1.66 
(Table 1). In the remaining 18 subjects (7%), there were no SLN 
revealed by this imaging modality. PL also defined directions of 
lymphatic drainage from the scar after primary lesion excision. In 
156 patients (61.2%), there was one region of lymphatic drainage, 
and in 75 patients (29.4%) there were two regions. In 3 patients, 
lymphatic drainage and sentinel nodes were observed in three ana-
tomical regions. Four different lymphatic drainage directions were 
detected in only 2 patients.
Lymphoscintigraphy performed by SPECT-CT revealed 497 sen-
tinel nodes in 253 patients. The number of lymph nodes located in 
one patient ranged from 1 to 6, with an average of 1.96 (Table 1). 
Only in 2 patients (0.7%) SLN was not revealed by SPECT/CT.
The SPECT-CT study also determined the pathways of lymphatic 
drainage from the area of the primary lesion. Sentinel nodes in 
one anatomical region were located in 153 cases (60%). Two lym-
phatic regions were sighted in 85 patients (33.3%). In the studied 
group, there were 3 patients who had lymphatic drainage to four 
anatomical regions in the SPECT-CT study. In these patients, the 
scar after the biopsy of the tumor was located in the upper part 
of the back in the midline. In another 11 patients (4.3%), three 
regions of lymphatic drainage were revealed. In this group, only 
two of primary lesions were located on the frontal surface of the 
trunk and the other 9 on the back of the midline or left side (7 and 
2 patients respectively).
Differences in the number of visible lymph nodes detected 
with PL and/or SPECT-CT between sexes and age groups were 
not statistically significant (p = 0.306).
SPECT-CT showed 497 sentinel nodes — 78 (18.6%) more than 
PL. In 40 patients additional lymph drainage regions (including 
nuchal, cervical, clavicular, iliac nodes) were located, not shown by 
planar imaging. In 18 patients (7.1%) SPECT-CT revealed sentinel 
nodes not visible in the PL (false-negative PL).
Particularly noteworthy is the group of 22 patients (8.6%), who 
had foci of enhanced activity in the PL, suggesting the presence 
of lymph nodes, that was not confirmed by the SPECT-CT. In three 
of these cases, the hot spot was identified as contamination of the 
skin, two of them were defined as a pathway of lymphatic drain-
age, and in the other 17 cases SPECT-CT images showed that the 
visible focus of increased activity interpreted as a sentinel node 
was a lymphatic vessel confluence (false positive PL).
In the analyzed group also the inconsistencies in the visualiza-
tion of lymphatic basins in PL and SPECT-CT were assessed (PS and 
SPECT-CT territory mismatch). SPECT-CT and PL outcomes were 
different in 31 patients (12.2%). SPECT-CT vs. PL mismatch was the 
most common in patients with primary lesions located in the anterior 
inferior medial region (75%) and the smallest in the posterior inferior 
medial area (0%). Data considering sensitivity, accuracy and PPV of 
both techniques are presented in the Table 1. In histopathological 
assessment of the SNB a total number of 637 lymph nodes were 
analysed. Melanoma metastases in histopathological examina-
tion were found in 83 lymph nodes (13%) in 64 patients (25.1%). 
There was a statistically significant difference in the incidence of 
metastases in individual age groups (p = 0.027709). The highest 
number of metastatic lesions was found for the age range 66–75 
years (32%), the smallest for the age group ≥ 75 (4%). There 
was also a statistically significant difference in the incidence of 
metastatic nodes depending on the location of the primary lesion 
(p = 0.002218), with the highest prevalence of metastases occurred 
for the patients with primary focus in the anterior inferior medial 
area (50%), while the lowest occurred in the posterior superior 
right region (16%).
The localization of primary melanoma lesions and the data on 
relative risk ratio for metastases from them are presented in Figure 1.
Discussion
Already in the eighties of the last century attention was paid 
to the multidirectional lymphatic drainage in cases of cutane-
ous melanoma located on the trunk [17]. The basis for analyzing 
the pathways of lymphatic drainage is to determine the anatomi-
cal region in which primary cancer is located. The most complex 
regional division of the body surface was proposed by Reynolds in 
2010. For statistical purposes, he defined over 30 anatomical 
regions [18]. In our opinion, such a complicated division has no 
significant clinical relevance and therefore our working definition 
of regions is based on commonly used anatomical terms, distin-
guishing twelve topographical areas. The simplest division into 
four anatomical regions was performed in 1993 by Uren, analyzing 
a group of 209 skin melanoma patients with primary lesions on the 
trunk [19]. Twenty-two of them had lymphatic drainage to three or 
more anatomical regions in a planar study, but the largest group 
of patients with melanoma located on the trunk was analyzed 
by this author in 2003 [20]. His study assessed the direction of 
lymphatic drainage in 211 patients with melanoma on the anterior 
surface and 1057 with melanoma on the posterior surface of the 
trunk. In this group, in 1164 patients, the tumor was in the up-
per trunk and in the remaining 104 below the transverse line of 
the trunk. In the entire study group, more than 25% patients had 
multidirectional lymph drainage, including cervical, retroperitoneal, 
perirenal and rib node [20].
Table 1. SPECT-CT located significantly more SLN in a larger group 
of patients and the average number of lymph nodes detected in one 
patient was significantly higher when SPECT-CT was performed. 
Analysis of PL revealed 95.1% sensitivity (P < 0.05, CI 90–95.1%) and 
positive predictive value (PPV) of 95.6% (p < 0.05, CI 93.4–97.3%). 
Accuracy (ACC) was 89.4% (p < 0.05, CI 86.5–91.9%). For the 
SPECT-CT test the sensitivity of the method was 98.6% (p < 0.05, CI 
97.1–99.4%), positive predictive value 99.8% (p < 0.05 CI 98.9–99.9%) 
and accuracy at 98.4% (p < 0.05, CI 96.8–99.3%)
PL SPECT/CT
Number of SLN/number of patients 419/236 497/253*
Average nodes/patient 1.66 1.96*
Sensitivity 95.1 98.6*
Accuracy 89.4 98.4*
PPV 95.6 99.8*
*p < 0.05 vs. PL
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In the recent work of El Muntasar examined group of 212 
patients and reported melanoma on the posterior surface of the 
trunk in 73% cases, and on the right side in 57%, however, he did 
not distinguish the central location [21]. The most extensive analy-
sis of the lateralization of melanoma was conducted by Brewster 
in 2007. This author, by analyzing the data of 98221 patients from 
6 European countries, reported a higher incidence of this tumor 
on the left side (RR 1.10, 95% CI 1.08–1.11) and presented the 
hypothesis explaining the phenomenon [22]. In our group of 255 
patients in 152 (59.6%) the primary lesion was located on the pos-
terior surface of the trunk and the remaining 103 on the anterior 
surface. In the upper part of the trunk 190 (74.5%) of lesions were 
found, and in the lower 65. In 96 (37.6%) patients, the primary lesion 
was present on the right site whereas 113 on the left site, and 46 
(18%) in the medial region. The differences observed in the distri-
bution of primary lesions may be due to the geographic regions in 
which the studies were conducted, varying exposure to sunlight, 
and different patterns of patient behavior [22].
With the development of hybrid imaging techniques, first 
proposals to supplement PL with SPECT-CT were made in the 
year 2003 [23]. In publications from this period it was stated that 
the SPECT-CT technique could be useful in determining the exact 
location of sentinel nodes in regions with complex anatomical 
structures [24]. In 2009, van der Ploeg demonstrated the benefits of 
SPECT-CT in the group of patients with difficulty in interpreting 
planar studies, stating that in 85 melanoma patients, including 31 
cases of melanoma on the trunk, the SPECT-CT study revealed 
an additional 12 lymph nodes in 7 patients. The author assessed 
that the SPECT-CT technique did not yield any additional informa-
tion in only 42% of the patients [25].
Recently many case reports from different centers have been 
published in which SPECT-CT was used to verify the results of 
PL [26–30]. Also, several studies that evaluated the number of 
additional lymph nodes and the benefits of SPECT-CT imaging 
in the skin-melanoma population in different locations have been 
published. In the Kraft’s study of 113 patients (including 55 with 
trunk localization), SPECT-CT showed 334 sentinel nodes, com-
pared with 253 detected in PL (36% more), and revealed lymph 
nodes in 8 (7.1%) patients with negative PL [15]. Similarly, Doepker 
analyzed a group of 351 skin malignancies patients (including 300 
with melanoma of different locations) in 172 (49%) of them reported 
additional lymph nodes not shown in PL [31]. Also Veenstra [32], 
evaluating a small group of 35 patients, stated that the SPECT-CT 
technique allowed for additional information in 16 of them [32].
Figure 1. Localization of primary tumour (A) and relative risk of metastasizing depending on region where the primary tumour is located (B). The 
trunk is divided into 12 areas as follows: anterior area — part of abdomen and thorax delimited laterally by midaxillary lines: anterior superior 
and anterior inferior areas delimited by abdominal transverse line (horizontal line passing through umbilicus), anterior lateral right and anterior 
lateral left areas delimited medially by parasternal lines, anterior medial area between both parasternal lines, posterior area — dorsal area 
delimited laterally by midaxillary lines: posterior superior and inferior areas delimited by extention of abdominal transverse line, posterior lateral 
right and posterior lateral left regions delimited medially by paravertebral line posterior medial area between both paravertebral lines
A B
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In our own material of SPECT-CT technique, 497 sentinel 
nodes were seen — 78 (18.6%) more than in the planar study. 
This number is almost two times smaller than that in the recent 
publications. The cause for such a difference may be a homo-
genous group of our patients and a large experience of the center 
in interpretation of PL images in search of SLNs. Similar results were 
obtained in a recent multicenter study, where the number of lymph 
nodes shown in the SPECT-CT study was only 13.1% greater than 
in PL [16].
In our analysis, 40 patients (15.7%) had additional lymph 
drainage regions not shown in planar imaging and in 18 (7.1%) 
cases SPECT-CT revealed SLNs not visualized by planar analysis. 
In 153 patients (60%) sentinel nodes were located in one anatomical 
region, in 85 (33.3%) in two regions, in 11 (4.3%) patients in three 
regions of the lymphatic drainage. There were 3 patients in the 
studied group, in which the SPECT-CT technique showed lymphatic 
flow to four anatomical regions. The number of patients diagnosed 
with multidirectional drainage is significantly higher than in some 
previous studies (40% in our group vs. 23.2% in e.g. Mc Hugh’s) 
[33]. However, the results we observe are similar to those pub-
lished by Fitzgerald, who analyzed a group of 214 skin melanoma 
patients and reported lymphatic drainage to single anatomical 
region in only 59.9% of patients with a primary lesion located on 
the trunk [34].
According to our knowledge, our study is one of the few done 
on such a homogeneous group of patients. The study included 
only patients with cutaneous melanoma located on the trunk after 
a biopsy of primary lesion. In the entire group analyzed, PL and 
SPECT-CT was performed in one center with extensive experience 
in performing radioisotope studies using the same protocol [35]. 
More common trunk melanoma in men (63%) and asymmetry in 
frequency of primary lesions occurrence (59.6% in the posterior 
area of the trunk, 44% in the left, 37.3% in the right and 18.7% in 
the medial region) was confirmed. It was also confirmed that in 
a significant group of patients (39.6%) the lymph flow was omni-
directional, incompatible with the predicted “anatomical” direction 
of the lymph nodes. Also, the mismatches found in various test 
techniques were assessed and described above.
In our study a total of 637 lymph nodes were collected and 
melanoma metastases were found in 83 nodes (13%) in 64 pa-
tients (25.1%). We established differences in the incidence of me-
tastases, in particular due to various age groups and locations of 
primary change — the highest prevalence of metastases was found 
for the age range 66–75 (32%) and for the anterior inferior medial 
area (50%), the lowest for the age group ≥ 75 (4%) and the pos-
terior superior right site (16%). These results are similar to those 
presented in the literature [35].
Recently, it is believed that in skin melanoma patients, the 
visualization of as many lymphatic drainage lines and sentinel 
nodes as possible may have significant prognostic implications. 
It is also believed that patients with multiple basins lymphatic 
drainage, with no metastases confirmed, have a better prognosis, 
however, the prognostic significance of multiple draining basins re-
mains controversial [36]. The precise three-dimensional localization 
of the lymph nodes in the SPECT-CT study reduces the number 
and extent of radical lymphadenectomy and often changes the 
scope of surgery, shortens its duration, thus reducing the number 
of possible surgical complications and shortening the duration of 
hospital stay [2, 37].
Results of the presented study indicates the high diagnostic 
value of hybrid techniques in assessment of sentinel nodes. The 
addition of SPECT-CT to preoperative diagnostics allowed not only 
to visualize a greater number of lymph nodes in relation to routine 
PL and additional lymphatic drainage regions, but also to detect foci 
of enhanced activity that were not sentinel nodes. Thus SPECT-CT 
imaging modality increases the sensitivity and accuracy of SLN 
identification in comparison to PL, even in very experienced hands.
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